Active Ingredient(s): Laronidase
FDA Approved: * April 30, 2003
Pharm Company: * BIOMARIN
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Aldurazyme Overview

Iduronidase (EC, L-iduronidase, alpha-L-iduronidase, laronidase), sold as Aldurazyme, is an enzyme with the systematic name glycosaminoglycan alpha-L-iduronohydrolase.[3][4][5] This enzyme catalyses the hydrolysis of unsulfated alpha-L-iduronosidic linkages in dermatan sulfate.[6] It is a glycoprotein enzyme found in the lysosomes of cells. It is involved in the degeneration of glycosaminoglycans such as dermatan sulfate...

Read more Aldurazyme Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Aldurazyme Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Solution: 2.9mg/5ml
  • Vial: 2.9mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Aldurazyme: (1 result)

Sorted by National Drug Code
  • 58468-0070 Aldurazyme 2.9 mg/5ml Intravenous Injection, Solution, Concentrate by Genzyme Corporation

Other drugs which contain Laronidase or a similar ingredient: (1 result)

Related Aldurazyme Topics:

Aldurazyme, MPS 1 & Life Expectancy
I'm an 18-year-old female taking Aldurazyme since the age of 10 and I have concerns about my life expectancy as it r...